<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343028">
  <stage>Registered</stage>
  <submitdate>6/06/2011</submitdate>
  <approvaldate>6/06/2011</approvaldate>
  <actrnumber>ACTRN12611000581965</actrnumber>
  <trial_identification>
    <studytitle>Aged garlic extract for uncontrolled hypertension: a dose-response trial</studytitle>
    <scientifictitle>Aged garlic extract or placebo for uncontrolled hypertension: a  randomised double-blind parallel dose response trial</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>treated uncontrolled hypertension</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Hypertension</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Alternative and complementary medicine</conditioncode1>
      <conditioncode2>Herbal remedies</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Active groups: Aged garlic extract (AGE, Kyolic) orally daily for 12 weeks
Group 1: 4 capsules containing 960 mg AGE, 2.4 mg S-AllylCysteine (SAC)
Group 2: 2 capsules containing 480 mg AGE, 1.2 mg SAC
Group 3: 1 capsule containing 240 mg AGE, 0.6 mg SAC</interventions>
    <comparator>Control groups: Placebo capsules orally matched in  size, colour, odour to the active treatment containing soy protein daily for 12 weeks

Group 4: 4 placebo capsules 
Group 5: 2 placebo capsules
Group 6: 1 placebo capsule</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Blood pressure, mean of three serial measures, with Omron HEM-907 sphyngomanometer by research assistant</outcome>
      <timepoint>0 (Baseline), 4, 8, 12 weeks since commencement of intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Acceptability by questionnaire using 5-point likert scales</outcome>
      <timepoint>12 weeks from baseline and commencement of intervention</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Blood pressure &gt; 140 mm Hg systolic under trial conditions; on established plan of BP medication (one or more classes) for at least 2 months</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Unable to give informed consent; unstable medical conditions or serious illness; severe hypertension (&gt; 180 mm Hg); already taking daily garlic supplements</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Hypertensive patients are identified by search of computerised medical practice records and a letter of invitation sent from the patient's general practice. Consenting patients will be screened for eligibility, enrolled if eligible by the research assistant, and assigned to one of 6 groups based on centralised randomisation.</concealment>
    <sequence>Permuted block randomisation using a computer generated random number sequence conducted by statistician offsite and not involved in the trial.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>4/07/2011</anticipatedstartdate>
    <actualstartdate>1/08/2011</actualstartdate>
    <anticipatedenddate>30/03/2012</anticipatedenddate>
    <actualenddate>28/03/2012</actualenddate>
    <samplesize>84</samplesize>
    <actualsamplesize>84</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>SA</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Karin Ried</primarysponsorname>
    <primarysponsoraddress>Discipline of General Practice
178 North Tce, Level 11
Adelaide, SA 5005</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Adelaide Hospital New Investigator Clinical Project Grant</fundingname>
      <fundingaddress>Discipline of General Practice
178 North Tce, Level 11
Adelaide, SA 5005</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Oliver Frank</sponsorname>
      <sponsoraddress>Discipline of General Practice
178 North Tce, Level 11
Adelaide, SA 5005</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Prof Nigel Stocks</othercollaboratorname>
      <othercollaboratoraddress>Discipline of General Practice
178 North Tce, Level 11
Adelaide, SA 5005</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study will investigate the efficacy, dose-reponse relationship and acceptability of aged garlic extract for reducing blood pressure in treated but uncontrolled hypertensive general practice patients.</summary>
    <trialwebsite />
    <publication>Ried K, Frank OR, Stocks N. Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial. Eur J Clin Nutr 2013, 67, 64-70</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The University of Adelaide Human Research Ethics Committee</ethicname>
      <ethicaddress>115 Grenfell St
The University of Adelaide
Adelaide, SA 5005</ethicaddress>
      <ethicapprovaldate>31/03/2011</ethicapprovaldate>
      <hrec>H-026-2011</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Karin Ried</name>
      <address>Discipline of General Practice
178 North Tce, Level 11
Adelaide, SA 5005</address>
      <phone>+61-8-8313-6281</phone>
      <fax>+61-8-8313-3511</fax>
      <email>karin.ried@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Karin Ried</name>
      <address>Discipline of General Practice
178 North Tce, Level 11
Adelaide, SA 5005</address>
      <phone>+61-8-8313-6281</phone>
      <fax>+61-8-8313-3511</fax>
      <email>karin.ried@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Karin Ried</name>
      <address>National Institute of Integrative Medicine
21 Burwood Rd
Hawthorn, VIC 3122</address>
      <phone>+ 61-3-9912 9545</phone>
      <fax>+61-3-9804-0513</fax>
      <email>karinried@niim.com.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Karin Ried</name>
      <address>National Institute of Integrative Medicine
21 Burwood Rd
Hawthorn, VIC 3122

at time of trial (2011-2012):
The University of Adelaide
Discipline of General Practice
Adelaide, SA 5005</address>
      <phone>+61 423 027 834</phone>
      <fax />
      <email>karinried@niim.com.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>